Literature DB >> 26786702

OSCAR-collagen signaling in monocytes plays a proinflammatory role and may contribute to the pathogenesis of rheumatoid arthritis.

Heidi S Schultz1,2, Li Guo3, Pernille Keller1, Andrew J Fleetwood4, Mingyi Sun3, Wei Guo3, Chunyan Ma3, John A Hamilton4, Olle Bjørkdahl1, Martin W Berchtold2, Svetlana Panina1.   

Abstract

Osteoclast-associated receptor (OSCAR) is an activating receptor expressed by human myeloid cells. Collagen type I (ColI) and collagen type II (ColII) serve as ligands for OSCAR. OSCAR-collagen interaction stimulates RANK-dependent osteoclastogenesis. We have recently reported that OSCAR promotes functional maturation of monocyte-derived dendritic cells. OSCAR is upregulated on monocytes from rheumatoid arthritis (RA) patients with active disease, and these monocytes show an increased proosteoclastogenic potential. In the current study, we have addressed a functional role for an OSCAR-collagen interaction on monocytes. We show that OSCAR-ColII signaling promoted the survival of monocytes. Moreover, ColII stimulated the release of proinflammatory cytokines by monocytes from healthy donors, which could be completely blocked by an anti-OSCAR monoclonal antibody. Mononuclear cells from the synovial fluid of RA patients plated on ColII secreted TNF-α and IL-8 in an OSCAR-dependent manner. Global RNA profiling showed that components of multiple signaling pathways relevant to RA pathogenesis are regulated at the transcriptional level by OSCAR in monocytes. Thus, OSCAR can play a proinflammatory role in monocyte-derived cells and may contribute crucially on multiple levels to RA pathogenesis.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Autoimmunity; Collagen; Inflammation; Monocyte; OSCAR; Rheumatoid arthritis

Mesh:

Substances:

Year:  2016        PMID: 26786702     DOI: 10.1002/eji.201545986

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  LAIR-1 shedding from human fibroblast-like synoviocytes in rheumatoid arthritis following TNF-α stimulation.

Authors:  Y Zhang; S Wang; H Dong; X Yi; J Zhang; X Liu; R Zhuang; Y Ding
Journal:  Clin Exp Immunol       Date:  2018-02-20       Impact factor: 4.330

2.  Osteoclast-Associated Receptor (OSCAR) Distribution in the Synovial Tissues of Patients with Active RA and TNF-α and RANKL Regulation of Expression by Osteoclasts In Vitro.

Authors:  Anak A S S K Dharmapatni; Kent Algate; Roxanne Coleman; Michelle Lorimer; Melissa D Cantley; Malcolm D Smith; Mihir D Wechalekar; Tania N Crotti
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

Review 3.  Osteoclasts in the Inflammatory Arthritis: Implications for Pathologic Osteolysis.

Authors:  Youn-Kwan Jung; Young-Mo Kang; Seungwoo Han
Journal:  Immune Netw       Date:  2019-02-20       Impact factor: 6.303

Review 4.  Inhibitory pattern recognition receptors.

Authors:  Matevž Rumpret; Helen J von Richthofen; Victor Peperzak; Linde Meyaard
Journal:  J Exp Med       Date:  2021-12-14       Impact factor: 17.579

Review 5.  The monocyte-to-osteoclast transition in rheumatoid arthritis: Recent findings.

Authors:  Naoki Iwamoto; Atsushi Kawakami
Journal:  Front Immunol       Date:  2022-09-12       Impact factor: 8.786

6.  Identification of Key Genes Involved in Diabetic Peripheral Neuropathy Progression and Associated with Pancreatic Cancer.

Authors:  Liumeng Jian; Guangda Yang
Journal:  Diabetes Metab Syndr Obes       Date:  2020-02-19       Impact factor: 3.168

Review 7.  Chronic Diabetic Wounds and Their Treatment with Skin Substitutes.

Authors:  Jordan Holl; Cezary Kowalewski; Zbigniew Zimek; Piotr Fiedor; Artur Kaminski; Tomasz Oldak; Marcin Moniuszko; Andrzej Eljaszewicz
Journal:  Cells       Date:  2021-03-15       Impact factor: 6.600

Review 8.  Immune Modulatory Properties of Collagen in Cancer.

Authors:  Anne Mette Askehøj Rømer; Marie-Louise Thorseth; Daniel Hargbøl Madsen
Journal:  Front Immunol       Date:  2021-12-08       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.